Intra-Cellular Therapies Company Profile (NASDAQ:ITCI)

About Intra-Cellular Therapies

Intra-Cellular Therapies logoIntra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system (CNS). The Company's pipeline includes approximately two product candidates in clinical development and two product candidates in advanced pre-clinical testing. Its platform includes ITI-007 platform and phosphodiesterase (PDE) Inhibitor Platform. It is developing its lead drug candidate, ITI-007, for the treatment of schizophrenia, behavioral disturbances associated with dementia, autism and other CNS diseases. Its ITI-007 platform also includes long acting injectable (LAI) program, and IC200131 program for mood and other disorders. Its PDE Inhibitor Platform includes PDE1 program and PDE2 and PDE9 programs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ITCI
  • CUSIP:
Key Metrics:
  • Previous Close: $42.35
  • 50 Day Moving Average: $41.73
  • 200 Day Moving Average: $37.37
  • 52-Week Range: $22.41 - $59.96
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -13.89
  • P/E Growth: 0.00
  • Market Cap: $1.83B
  • Outstanding Shares: 43,251,000
  • Beta: 0.81
Profitability:
  • Return on Equity: -25.78%
  • Return on Assets: -25.08%
Debt:
  • Current Ratio: 23.06%
  • Quick Ratio: 23.05%
Additional Links:
Companies Related to Intra-Cellular Therapies:

Analyst Ratings

Consensus Ratings for Intra-Cellular Therapies (NASDAQ:ITCI) (?)
Ratings Breakdown: 6 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.14)
Consensus Price Target: $74.29 (75.41% upside)

Analysts' Ratings History for Intra-Cellular Therapies (NASDAQ:ITCI)
Show:
DateFirmActionRatingPrice TargetDetails
9/13/2016Piper Jaffray Cos.Reiterated RatingOverweight$57.00View Rating Details
8/11/2016Leerink SwannReiterated RatingBuy$95.00View Rating Details
8/5/2016Cowen and CompanyReiterated RatingBuy$75.00View Rating Details
3/29/2016SunTrust Banks Inc.Reiterated RatingTop Pick$60.00View Rating Details
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$62.00 -> $55.00View Rating Details
11/6/2015Royal Bank Of CanadaBoost Price TargetOutperform$62.00 -> $74.00View Rating Details
9/29/2015GuggenheimBoost Price TargetBuy$95.00 -> $104.00View Rating Details
9/17/2015Ladenburg ThalmannReiterated RatingBuy$54.00 -> $75.00View Rating Details
(Data available from 9/28/2014 forward)

Earnings

Earnings History for Intra-Cellular Therapies (NASDAQ:ITCI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.79)($0.71)$0.02 million$0.23 millionViewN/AView Earnings Details
4/28/2016Q116($0.78)($0.64)$0.02 millionViewListenView Earnings Details
2/25/2016Q415($0.87)($0.67)$0.05 million$30.66 millionViewListenView Earnings Details
11/5/2015Q315($0.66)($0.91)ViewN/AView Earnings Details
8/5/2015Q215($0.72)($0.61)$40.00 million$57.40 millionViewN/AView Earnings Details
4/30/2015Q1($0.68)($0.72)ViewN/AView Earnings Details
3/12/2015($0.49)($0.52)ViewN/AView Earnings Details
11/3/2014Q314($0.28)($0.22)ViewN/AView Earnings Details
8/12/2014Q214($0.23)($0.15)ViewN/AView Earnings Details
5/8/2014($0.23)($0.17)ViewN/AView Earnings Details
3/26/2014($0.41)($0.36)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Intra-Cellular Therapies (NASDAQ:ITCI)
Current Year EPS Consensus Estimate: $-3.16 EPS
Next Year EPS Consensus Estimate: $-3.05 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.74)($0.63)($0.69)
Q2 20162($0.79)($0.65)($0.72)
Q3 20163($0.82)($0.66)($0.71)
Q4 20161($0.93)($0.93)($0.93)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Intra-Cellular Therapies (NASDAQ:ITCI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Intra-Cellular Therapies (NASDAQ:ITCI)
Insider Ownership Percentage: 19.80%
Institutional Ownership Percentage: 70.15%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/29/2016Christopher D AlafiDirectorBuy100,000$29.70$2,970,000.00View SEC Filing  
12/15/2015Lawrence J. HinelineCFOSell45,000$51.45$2,315,250.00View SEC Filing  
12/11/2015Sharon MatesCEOSell51,500$53.87$2,774,305.00View SEC Filing  
12/8/2015Joel S MarcusDirectorSell92,700$54.47$5,049,369.00View SEC Filing  
11/24/2015Lawrence J HinelineCFOSell5,000$55.00$275,000.00View SEC Filing  
6/8/2015Lawrence P WennogleVPSell25,000$26.84$671,000.00View SEC Filing  
3/11/2015Christopher D AlafiDirectorBuy625,000$24.00$15,000,000.00View SEC Filing  
12/9/2014Lawrence J HinelineCFOSell22,500$16.71$375,975.00View SEC Filing  
12/1/2014Moshe AlafiMajor ShareholderBuy1,422$14.75$20,974.50View SEC Filing  
11/28/2014Christopher D AlafiDirectorBuy35,000$14.75$516,250.00View SEC Filing  
11/19/2014Alafi Capital Co LlcMajor ShareholderBuy1,034$14.25$14,734.50View SEC Filing  
11/18/2014Alafi Capital Co LlcMajor ShareholderBuy3,664$14.26$52,248.64View SEC Filing  
11/13/2014Alafi Capital Co LlcMajor ShareholderBuy12,200$15.34$187,148.00View SEC Filing  
11/6/2014Michael HalsteadSVPBuy20,000$15.38$307,600.00View SEC Filing  
10/15/2014Lawrence P WennogleVPSell3,604$15.00$54,060.00View SEC Filing  
10/13/2014Lawrence P WennogleVPSell1,600$15.00$24,000.00View SEC Filing  
10/8/2014Lawrence P WennogleVPSell4,745$15.00$71,175.00View SEC Filing  
10/6/2014Lawrence P WennogleVPSell16,499$15.00$247,485.00View SEC Filing  
9/15/2014Lawrence P WennogleVPSell5,000$15.00$75,000.00View SEC Filing  
9/8/2014Lawrence J HinelineCFOSell300$15.00$4,500.00View SEC Filing  
5/22/2014Lawrence P WennogleVPSell6,000$15.00$90,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Intra-Cellular Therapies (NASDAQ:ITCI)
DateHeadline
forbes.com logoNoteworthy Tuesday Option Activity: GOOGL, ITCI, N - Forbes (NASDAQ:ITCI)
www.forbes.com - September 28 at 5:30 PM
streetinsider.com logoIntra-Cellular Therapies (ITCI) Announces ITI-007 Phase 3 Missed Primary Endpoint in Schizophrenia - StreetInsider.com (NASDAQ:ITCI)
www.streetinsider.com - September 28 at 5:30 PM
realistinvestor.com logoIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Is Expected To Post EPS Of $-0.95 - RealistInvestor.com (NASDAQ:ITCI)
www.realistinvestor.com - September 28 at 5:30 PM
biz.yahoo.com logoINTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:ITCI)
biz.yahoo.com - September 28 at 5:30 PM
marketwatch.com logoIntra-Cellular Therapies shares halted (NASDAQ:ITCI)
www.marketwatch.com - September 28 at 5:30 PM
publicnow.com logoIntra-Cellular Therapies Announces Top-Line Results from the Second Phase 3 Trial of ITI-007 in Patients with Schizophrenia (Study ‘302) (NASDAQ:ITCI)
www.publicnow.com - September 28 at 5:30 PM
marketwatch.com logoIntra-Cellular Therapies shares plunge 68% after study results (NASDAQ:ITCI)
www.marketwatch.com - September 28 at 5:30 PM
wsj.com logo[$$] Intra-Cellular Therapies Shares Plunge After Disappointing Drug Trial Results (NASDAQ:ITCI)
www.wsj.com - September 28 at 5:30 PM
capitalcube.com logoIntra-Cellular Therapies, Inc. breached its 50 day moving average in a Bullish Manner : ITCI-US : September 26, 2016 (NASDAQ:ITCI)
www.capitalcube.com - September 26 at 10:20 AM
investornewswire.com logoShares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Expected To Hit $95 - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - September 22 at 3:51 PM
News IconStock to keep an eye on: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Theriponadvance.com (NASDAQ:ITCI)
theriponadvance.com - September 22 at 3:51 PM
News IconIntra-Cellular Therapies, Inc.'s (ITCI): Stock Analysis Review - Hot Stocks Point (NASDAQ:ITCI)
www.hotstockspoint.com - September 22 at 3:51 PM
reuters.com logoAllergan pays top dollar for 'stepping stones' from neurology to dermatolo... - Reuters (NASDAQ:ITCI)
www.reuters.com - September 20 at 10:48 AM
News IconPiper Jaffray Begins Coverage on Intra-Cellular Therapies Inc (ITCI) - DailyQuint (NASDAQ:ITCI)
dailyquint.com - September 17 at 10:14 AM
investornewswire.com logoIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Posted A Surprise Factor Of 10.13 Percent - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - September 15 at 6:08 PM
investornewswire.com logoCan Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95 - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - September 15 at 8:55 AM
realistinvestor.com logoIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Is Expected To Post ... - RealistInvestor.com (NASDAQ:ITCI)
www.realistinvestor.com - September 14 at 5:49 PM
fool.com logo3 All-or-Nothing Biotechs I'm Watching Like a Hawk (NASDAQ:ITCI)
www.fool.com - September 12 at 10:26 AM
News IconPlacing Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Shares Under the Microscope - Post News (NASDAQ:ITCI)
www.kentuckypostnews.com - September 9 at 5:29 PM
capitalcube.com logoIntra-Cellular Therapies, Inc. – Value Analysis (NASDAQ:ITCI) : September 8, 2016 (NASDAQ:ITCI)
www.capitalcube.com - September 8 at 5:36 PM
News IconStock Sliding Down Over the Last Month: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Post News (NASDAQ:ITCI)
www.kentuckypostnews.com - September 8 at 9:37 AM
capitalcube.com logoIntra-Cellular Therapies, Inc. breached its 50 day moving average in a Bullish Manner : ITCI-US : September 7, 2016 (NASDAQ:ITCI)
www.capitalcube.com - September 7 at 9:09 AM
investornewswire.com logoCan Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Get To $95? - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - September 3 at 10:12 AM
feeds.reuters.com logoBRIEF-Intra-Cellular Therapies files for mixed shelf of up to $350 mln (NASDAQ:ITCI)
feeds.reuters.com - September 2 at 6:46 PM
capitalcube.com logoETF’s with exposure to Intra-Cellular Therapies, Inc. : August 29, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 29 at 5:35 PM
investornewswire.com logoIntra-Cellular Therapies Inc. (NASDAQ:ITCI) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - August 26 at 5:34 PM
capitalcube.com logoIntra-Cellular Therapies, Inc. breached its 50 day moving average in a Bearish Manner : ITCI-US : August 26, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 26 at 8:41 AM
News IconCrowd is Weighing in on Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Post News (NASDAQ:ITCI)
www.kentuckypostnews.com - August 21 at 5:12 PM
capitalcube.com logoETF’s with exposure to Intra-Cellular Therapies, Inc. : August 18, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 19 at 8:42 AM
investornewswire.com logoWill Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95 Price Target? - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - August 18 at 5:44 PM
realistinvestor.com logoAnalysts See Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Reporting EPS Of $-0.95 - RealistInvestor.com (NASDAQ:ITCI)
www.realistinvestor.com - August 18 at 5:44 PM
finance.yahoo.com logoINTRA-CELLULAR THERAPIES, INC. Financials (NASDAQ:ITCI)
finance.yahoo.com - August 12 at 5:49 PM
equities.com logoIntra-Cellular Therapies Inc. (ITCI) is Trading Higher on Unusual Volume for August 08 - Equities.com (NASDAQ:ITCI)
www.equities.com - August 10 at 8:37 AM
fortune.com logoNotable Analyst Coverage: SUPERVALU INC. (NYSE:SVU), Intra-Cellular Therapies Inc (NASDAQ:ITCI) - Review Fortune (NASDAQ:ITCI)
reviewfortune.com - August 9 at 5:53 PM
News IconBiggest Healthcare Movers: Exact Sciences Corporation (NASDAQ:EXAS), Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TWN (NASDAQ:ITCI)
thewellesleysnews.com - August 9 at 5:53 PM
capitalcube.com logoETF’s with exposure to Intra-Cellular Therapies, Inc. : August 8, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 8 at 5:54 PM
marketnewsvideo.com logoNoteworthy Friday Option Activity: CPSI, BA, ITCI (NASDAQ:ITCI)
www.marketnewsvideo.com - August 6 at 8:36 AM
capitalcube.com logoIntra-Cellular Therapies, Inc. :ITCI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 (NASDAQ:ITCI)
www.capitalcube.com - August 5 at 5:52 PM
sg.finance.yahoo.com logoIntra-Cellular reports 2Q loss (NASDAQ:ITCI)
sg.finance.yahoo.com - August 4 at 6:01 PM
finance.yahoo.com logo7:06 am Intra-Cellular Therapies beats by $0.08, beats on revs (NASDAQ:ITCI)
finance.yahoo.com - August 4 at 8:46 AM
biz.yahoo.com logoINTRA-CELLULAR THERAPIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Finan (NASDAQ:ITCI)
biz.yahoo.com - August 4 at 8:46 AM
publicnow.com logoIntra-Cellular Therapies Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:ITCI)
www.publicnow.com - August 4 at 8:46 AM
investornewswire.com logoCan Shares Of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) Hit $95? - Investor Newswire (NASDAQ:ITCI)
www.investornewswire.com - July 28 at 8:44 AM
publicnow.com logoIntra-Cellular Therapies to Host Second Quarter 2016 Financial Results Conference Call and Webcast (NASDAQ:ITCI)
www.publicnow.com - July 25 at 8:18 AM
News IconWere Analysts Bearish Intra-Cellular Therapies Inc (NASDAQ:ITCI) This Week? - Consumer Eagle (NASDAQ:ITCI)
www.consumereagle.com - July 22 at 5:38 PM
news.cmlviz.com logoIntra-Cellular Therapies Inc (NASDAQ:ITCI) Stock Technicals Hit Strength - CML News (NASDAQ:ITCI)
news.cmlviz.com - July 22 at 5:38 PM
News IconShares Positive Over the Past Month: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TGP (NASDAQ:ITCI)
telanaganapress.com - July 20 at 8:43 AM
News IconEquity Roundup: Stock Performance Focus on Intra-Cellular Therapies Inc. (NASDAQ:ITCI) - Press Telegraph (NASDAQ:ITCI)
presstelegraph.com - July 19 at 11:49 AM
News IconStock in Positive Territory for the Quarter: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - Engelwood Daily (NASDAQ:ITCI)
www.engelwooddaily.com - July 18 at 5:53 PM
News IconShares Experiencing a Downtrend: Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) - TGP (NASDAQ:ITCI)
telanaganapress.com - July 17 at 5:15 PM

Social

Intra-Cellular Therapies (NASDAQ:ITCI) Chart for Wednesday, September, 28, 2016


Last Updated on 9/28/2016 by MarketBeat.com Staff